Reategui E - Search Results

1

Acceptability of a Rinse Screening Test for Diagnosing Head and Neck Squamous Cell Carcinoma Among Black Americans.

Lechner SC, Pereira L, Reategui E, Gordon C, Byrne M, Hooper MW, Lee DJ, Abouyared M, Franzmann E. Lechner SC, et al. Among authors: reategui e. J Racial Ethn Health Disparities. 2015 Mar;2(1):62-7. doi: 10.1007/s40615-014-0048-9. Epub 2014 Sep 11. J Racial Ethn Health Disparities. 2015. PMID: 26863242

2

Erratum to: Acceptability of a Rinse Screening Test for Diagnosing Head and Neck Squamous Cell Carcinoma Among Black Americans.

Lechner SC, Pereira L, Reategui E, Gordon C, Byrne M, Hooper MW, Lee DJ, Abouyared M, Franzmann E. Lechner SC, et al. Among authors: reategui e. J Racial Ethn Health Disparities. 2015 Mar;2(1):68. doi: 10.1007/s40615-014-0082-7. J Racial Ethn Health Disparities. 2015. PMID: 26863243 No abstract available.

3

Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma.

Franzmann EJ, Reategui EP, Pereira LH, Pedroso F, Joseph D, Allen GO, Hamilton K, Reis I, Duncan R, Goodwin WJ, Hu JJ, Lokeshwar VB. Franzmann EJ, et al. Head Neck. 2012 May;34(5):687-95. doi: 10.1002/hed.21810. Epub 2011 Jul 11. Head Neck. 2012. PMID: 22294418 Free PMC article.

4

CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression.

Perez A, Neskey DM, Wen J, Pereira L, Reategui EP, Goodwin WJ, Carraway KL, Franzmann EJ. Perez A, et al. Oral Oncol. 2013 Apr;49(4):306-13. doi: 10.1016/j.oraloncology.2012.11.009. Epub 2012 Dec 20. Oral Oncol. 2013. PMID: 23265944 Free PMC article.

5

Risk Stratification System for Oral Cancer Screening.

Pereira LH, Reis IM, Reategui EP, Gordon C, Saint-Victor S, Duncan R, Gomez C, Bayers S, Fisher P, Perez A, Goodwin WJ, Hu JJ, Franzmann EJ. Pereira LH, et al. Cancer Prev Res (Phila). 2016 Jun;9(6):445-55. doi: 10.1158/1940-6207.CAPR-15-0200. Epub 2016 Mar 28. Cancer Prev Res (Phila). 2016. PMID: 27020654 Free PMC article.

6

Salivary soluble CD44: a potential molecular marker for head and neck cancer.

Franzmann EJ, Reategui EP, Carraway KL, Hamilton KL, Weed DT, Goodwin WJ. Franzmann EJ, et al. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):735-9. doi: 10.1158/1055-9965.EPI-04-0546. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15767360

7

Characterization of CD44v3-containing isoforms in head and neck cancer.

Reategui EP, de Mayolo AA, Das PM, Astor FC, Singal R, Hamilton KL, Goodwin WJ, Carraway KL, Franzmann EJ. Reategui EP, et al. Cancer Biol Ther. 2006 Sep;5(9):1163-8. doi: 10.4161/cbt.5.9.3065. Epub 2006 Sep 11. Cancer Biol Ther. 2006. PMID: 16855392

8

Soluble CD44 is a potential marker for the early detection of head and neck cancer.

Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, Hamilton K, Singal R, Goodwin WJ. Franzmann EJ, et al. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1348-55. doi: 10.1158/1055-9965.EPI-06-0011. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17627000

9

An Alu insertion polymorphism in a baboon hybrid zone.

Szmulewicz MN, Andino LM, Reategui EP, Woolley-Barker T, Jolly CJ, Disotell TR, Herrera RJ. Szmulewicz MN, et al. Among authors: reategui ep. Am J Phys Anthropol. 1999 May;109(1):1-8. doi: 10.1002/(SICI)1096-8644(199905)109:1<1::AID-AJPA1>3.0.CO;2-X. Am J Phys Anthropol. 1999. PMID: 10342460

10

Single-nucleotide variant in multiple copies of a deleted in azoospermia (DAZ) sequence - a human Y chromosome quantitative polymorphism.

Szmulewicz MN, Ruiz LM, Reategui EP, Hussini S, Herrera RJ. Szmulewicz MN, et al. Hum Hered. 2002;53(1):8-17. doi: 10.1159/000048599. Hum Hered. 2002. PMID: 11901266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page